1 / 8

Global Oncolytic Virus Therapy Market Research and Forecast, 2018-2023

Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma.

omrglobal
Télécharger la présentation

Global Oncolytic Virus Therapy Market Research and Forecast, 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Oncolytic Virus Therapy Market Research and Forecast, 2018-2023 Global oncolytic virus therapy market size, share, market intelligence, company profiles, market trends, growth, strategy, research report, analysis, overview, forecast 2018-2023

  2. DEFINITION Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses.

  3. MARKET MOTIVATORS • Increasing prevalence of melanoma cancer • Negative effects associated with conventional treatments such as chemotherapy • Growing investments in oncolytic virus R&D

  4. MARKET SEGMENTATION BY PRODUCT • HSV-Based oncolytic viruses • Adenoviruses-based oncolytic viruses • Vaccinia virus-based oncolytic viruses • Vesicular stomatitis virus-based oncolytic viruses • Newcastle disease virus-based oncolytic viruses

  5. MARKET SEGMENTATION

  6. REGION COVERED

  7. MARKET PLAYERS • Amgen Inc. • F. Hoffmann-La Roche Ltd. • Merck KGaA • Takara Bio, Inc. • Transgene SA

  8. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market/

More Related